Invitation to CELLINK's conference call on the acquisition of Scienion AG

CELLINK invites to a webcast/teleconference regarding the acquisition of Scienion AG. During the presentation, the CEO and CFO will inform about the acquisition and answer questions about the transaction.  Below are the dial-in details:

August 20th 2020 15:00 (Europe/Stockholm)

Language: English

Sector: Health care - Equipment & Services

Activity: Pressconference


Teleconference: Dial-in number FR: +33170750721 DE: +4969222220380 SE: +46851999383 UK: +443333009032 US: 18335268383

The presentation will be uploaded to the company's IR page and the material is available here:

For further information, please contact:

Erik Gatenholm, CEO                                                            Gusten Danielsson, CFO

Phone (Sweden): +46 73 267 00 00                                  Phone (Sweden): +46 70 991 86 04

Phone (US): +1 (650) 515 5566                                          Phone (US): +1 (857) 332 2138

Email: [email protected]                                                            Email: [email protected]


CELLINK is a global life-science company providing technologies, products, and services to create, understand, and master cell and molecular biology, with a focus on three main application areas: bioprinting, analysis, and liquid handling & bioprocessing. The company develops and markets innovative cell culture technologies, enabling researchers in the life sciences to print human organs and tissues for pharmaceutical and cosmetic applications. Founded in 2016, CELLINK’s products have been adopted by researchers and scientists in more than 1,000 laboratories with more than 100 publication citations, the majority of the largest pharmaceutical companies and has been delivered to more than 55 countries around the world. The company’s vision is to create the future of medicine.

Visit to learn more. CELLINK is listed on Nasdaq Stockholm Main Market under CLNK B.

Latest press releases